Improved immunoassay involving mutant antigens to reduce unspecific binding

Details for Australian Patent Application No. 2007283186 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. Suppremol GmbH

Inventors Jacob, Uwe; Huber, Robert; Breithaupt, Constanze

Agent Davies Collison Cave

Pub. Number AU-A-2007283186

PCT Pub. Number WO2008/017363

Priority EP06016554.5 08.08.06 EP

Filing date 12 July 2007

Wipo publication date 14 February 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/017363 Priority application(s): WO2008/017363

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007283195-Reinforced hose

2007283184-2-(heterocyclylbenzyl)pyridazinone derivatives